US can’t afford fall boosters for all—even after cuts to test and PPE spending
by Beth Mole from Ars Technica - All content on (#606H8)
Enlarge (credit: Getty | Spence Platt)
With pandemic funding running out, the Biden administration is repurposing $10 billion to buy next-generation COVID-19 booster doses for the fall, as well as treatments, including the anti-viral Paxlovid and monoclonal antibodies.
The funding will be pilfered from federal programs that support COVID-19 test availability and domestic production, as well as stockpiles of essential resources, such as personal protective equipment (PPE) and ventilators. Funding for research on coronavirus vaccines and new treatments will also take a hit.
"These were incredibly painful decisions," White House COVID-19 Response Coordinator Ashish Jha said in a press briefing Thursday.
Read 9 remaining paragraphs | Comments